Company: BSX
Filing Date: 2025-05-01
Form Type: 10-Q
Source: 0000885725-25-000026
Chunk: 29

Company: BOSTON SCIENTIFIC CORP
Filing Date: 2025-05-01
Form: 10-Q
Item: Part I, Item 1
Chunk 29
---
 2024(2,251)(2,251)Additional paid-in capital21,127 21,056 Retained earnings3,347 2,673 Accumulated other comprehensive income (loss), net of tax(28)275 Total stockholders’ equity22,212 21,770 Noncontrolling interests233 233 Total equity22,446 22,003 TOTAL LIABILITIES AND EQUITY$40,140 $39,395 

Refer to notes to the unaudited consolidated financial statements. Amounts may not add due to rounding.

5

BOSTON SCIENTIFIC CORPORATION AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (UNAUDITED)

Three Months Ended March 31,(in millions, except share data)20252024Common stock shares issued   Beginning1,737,846,196 1,729,000,224 Impact of stock-based compensation plans4,642,132 4,293,661    Ending1,742,488,328 1,733,293,885 Common stock   Beginning$17 $17 Impact of stock-based compensation plans0 0    Ending$17 $17 Treasury stockBeginning$(2,251)$(2,251)Repurchase of common stock— — Ending$(2,251)$(2,251)Additional paid-in capitalBeginning$21,056 $20,647 Impact of stock-based compensation plans70 66 Ending$21,127 $20,713 Retained earningsBeginning$2,673 $819 Net income (loss)672 493 Net (income) loss attributable to noncontrolling interests2 1 Ending$3,347 $1,314 Accumulated other comprehensive income (loss), net of tax Beginning$275 $49 Changes in other comprehensive income (loss)(302)83 Ending$(28)$132 Total stockholders' equity$22,212 $19,926 Noncontrolling interestsBeginning$233 $248 Net income (loss) attributable to noncontrolling interests(2)(1)Changes in other comprehensive income (loss)2 (5)Ending$233 $242 Total equity$22,446 $20,168 

Refer to notes to the unaudited consolidated financial statements. Amounts may not add due to rounding